- Previous Close
2.3800 - Open
2.3800 - Bid 2.3400 x --
- Ask 2.5200 x --
- Day's Range
2.3800 - 2.3800 - 52 Week Range
1.3300 - 4.4000 - Volume
500 - Avg. Volume
44 - Market Cap (intraday)
83.169M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.
www.monogramorthopedics.comRecent News: J7J.F
View MorePerformance Overview: J7J.F
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: J7J.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: J7J.F
View MoreValuation Measures
Market Cap
83.31M
Enterprise Value
67.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
212.52
Price/Book (mrq)
4.83
Enterprise Value/Revenue
190.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-60.92%
Return on Equity (ttm)
-121.56%
Revenue (ttm)
365k
Net Income Avi to Common (ttm)
-11.69M
Diluted EPS (ttm)
-0.4600
Balance Sheet and Cash Flow
Total Cash (mrq)
7.31M
Total Debt/Equity (mrq)
6.10%
Levered Free Cash Flow (ttm)
-12.58M